Quick Answer
ENDONOVO THERAPEUTICS, INC. reported Net Income of -$18.47 million for fiscal year 2022.
ENDONOVO THERAPEUTICS, INC. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2022 | -$18.47M | -495.0% |
| 2021 | -$3.10M | -684.9% |
| 2020 | -$395.6K | +97.7% |
| 2019 | -$17.31M | -169.0% |
| 2018 | -$6.44M | +40.5% |
| 2017 | -$10.81M | -103.4% |
| 2016 | -$5.32M | +21.4% |
| 2015 | -$6.77M | -605.1% |
| 2014 | -$959.5K | -919.8% |
| 2011 | -$94.1K | -35.6% |
| 2010 | -$69.4K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$766.2K | -27.0% | -137.1% |
| June 30, 2023 | $2.06M | +181.7% | -71.5% |
| March 31, 2023 | $7.23M | +399.6% | +1298.4% |
| September 30, 2022 | -$603.4K | +60.4% | +76.1% |
| June 30, 2022 | -$2.53M | -94.8% | -4.7% |
| March 31, 2022 | -$2.41M | +10.0% | -58.4% |
| September 30, 2021 | -$1.52M | -42.5% | -17.5% |
| June 30, 2021 | -$1.30M | +20.7% | +51.6% |
- ENDONOVO THERAPEUTICS, INC. showed a decrease of -495.0% in Net Income compared to the prior fiscal year.
- Over the 2010–2022 period, ENDONOVO THERAPEUTICS, INC.’s net income has declined by 26520.8% (from -$69.4 thousand to -$18.47 million).
- The most recent figure is from ENDONOVO THERAPEUTICS, INC.’s fiscal year 2022 report (Form 10-K), filed with the SEC on April 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: